This article briefly outlines the efficacy and safety data of the drug treatment pipeline for obesity, with a focus on incretin-based medications, and discusses the clinical challenges and significance brought about by this new era
Tel: +82-2-2286-1092, Fax: +82-2-921-4355, [email protected] Copyright 2014 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
There is no procedural downtime
Proopiomelanocortin in the hypothalamus is converted to ACTH, Beta-lipoprotein, and gamma melanocyte-stimulating hormone (MSH)
After you place your order, we'll assess the destination and promptly inform you if any extra charges apply